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Introduction: In the world there are about 71 million people who have an HCV 
infection. Approximately half of the fatal cases are caused by cirrhosis and hepatocellular 
carcinoma. 
Aim: To study the severity of the cytolytic, mesenchymal-inflammatory and 
cholestasis syndrome in patients with chronic viral hepatitis C 
Materials and methods: 72 patients with chronic viral hepatitis C were 
examined prior to appointment of antiviral therapy. To study the activity of the cytolytic 
syndrome, the levels of AST and ALT were analyzed, the De Rithis coefficient was 
calculated; mesenchymal-inflammatory syndrome – ESR, protein and albumin levels; 
syndrome of cholestasis – bilirubin, alkaline phosphatase. 
Results: Among all patients with chronic viral hepatitis C who were on antiviral 
therapy, men (73.00%) were 2.7 times more than women (27.00%). The average age of 
patients was 44.69 ± 1.39. Almost equally were persons of young and middle age (47.62% 
and 42.86%), it is much less than elderly people (9.52%). Almost all patients had a 
subclinical course of acute hepatitis C and only 4.76% of patients had acute hepatitis in 
the anamnesis. Most of the examined had F2 fibrose (32.73%), which was 1.5 times more 
frequent than F0 (21.82%) and F4 (21.82%), and almost 2.5 times more than F3 (12.73%) 
and F1 (10.9%). Among patients with chronic viral hepatitis C prevailed patients with 
ALT value to 120 OD (73.61%) that is 1.5 times more, than the person with value in the 
range from 120 to 400 OD (23.61%). The number of people with values more than 400 
OD was only 2.78%. Analyzing the level of AST, the first place was also occupied by 
patients who had a minimum activity process for this indicator, that is, values in the range 
of 120 OD (84.72%), the second place was taken by a group of patients with moderate 
activity (13.89%) and the smallest part were patients with severe activity (1.39%). 
Calculating the De Rithis coefficient (AST / ALT), it was found that only 6.94% of 
patients showed an increase, indicating severe liver damage with the destruction of most of the 
hepatocyte only in these patients, while in other patients with elevated activity, only the 
membrane destruction, which had no effect on the deep structures of the liver cells. 
Studying the laboratory signs of mesenchymal-inflammatory syndrome, it was 
found that in 29.17% of patients, ESR was increades, in 6.90% was observed the 
hypoproteinemia, with a decrease in albumin levels in 16.33% of patients. 
The level of total bilirubin was increased in almost a third of patients (36.21%), 
while in other two thirds (63.79%) of patients it remained within normal limits. 
Increasing of alkaline phosphatase (15.25%) was noted 5.6 times less frequently 
than the normal level of this enzyme in the blood of patients. 
Conclusions: Thus, the most expressed in examined was cholestasis syndrome 
and mesenchymal-inflammatory syndrome, and the least pronounced – cytolytic, which 
may be due to the formation of fibrosis of varying degrees of most patients. 
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